[go: up one dir, main page]

AR080295A1 - Composiciones para el cuidado bucal y metodos de tratamiento - Google Patents

Composiciones para el cuidado bucal y metodos de tratamiento

Info

Publication number
AR080295A1
AR080295A1 ARP110100556A ARP110100556A AR080295A1 AR 080295 A1 AR080295 A1 AR 080295A1 AR P110100556 A ARP110100556 A AR P110100556A AR P110100556 A ARP110100556 A AR P110100556A AR 080295 A1 AR080295 A1 AR 080295A1
Authority
AR
Argentina
Prior art keywords
compositions
oral care
treatment methods
weight
active ingredients
Prior art date
Application number
ARP110100556A
Other languages
English (en)
Inventor
Pillai Shyamala
Fei Lin
Subramanyam Ravi
Guofeng Xu
Yang Ying
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR080295A1 publication Critical patent/AR080295A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/49—Solubiliser, Solubilising system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Reivindicacion 1: Una composicion bucal caracterizada porque comprende: desde 0,05 hasta 10% en peso de polietilenglicol; desde 0,05 hasta 5% en peso de por lo menos uno o más ingredientes activos que se encuentran en el extracto de magnolia o un análogo sintético del mismo, caracterizado porque por lo menos uno de uno o más ingredientes activos se selecciona del grupo que consiste de extracto de magnolia, magnolol, honokiol, tetrahidromagnolol, tetrahidrohonokiol (propilhonokiol), 5,5'-di-n-butil-bifenil-2,2'-diol, así como una combinacion de dos o más de los mismos; y un portador aceptable bucalmente.
ARP110100556A 2010-02-24 2011-02-24 Composiciones para el cuidado bucal y metodos de tratamiento AR080295A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30767310P 2010-02-24 2010-02-24

Publications (1)

Publication Number Publication Date
AR080295A1 true AR080295A1 (es) 2012-03-28

Family

ID=44507552

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100556A AR080295A1 (es) 2010-02-24 2011-02-24 Composiciones para el cuidado bucal y metodos de tratamiento

Country Status (16)

Country Link
US (1) US8956592B2 (es)
EP (1) EP2539022B1 (es)
JP (2) JP2013520518A (es)
CN (1) CN103025305A (es)
AR (1) AR080295A1 (es)
AU (1) AU2011220790B2 (es)
BR (1) BR112012019190A2 (es)
CA (1) CA2787965C (es)
MX (1) MX2012008717A (es)
MY (1) MY161595A (es)
PH (1) PH12012501522A1 (es)
RU (1) RU2012140346A (es)
SG (1) SG182711A1 (es)
TW (1) TWI459957B (es)
WO (1) WO2011106493A2 (es)
ZA (1) ZA201205804B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2655304B1 (en) 2010-12-21 2017-12-06 Colgate-Palmolive Company Halogenated biphenols as antibacterial agents
RU2014126871A (ru) * 2011-12-02 2016-02-10 Колгейт-Палмолив Компани Композиции для гигиены полости рта
MX345779B (es) * 2011-12-02 2017-02-15 Colgate Palmolive Co Composiciones de cuidado bucal.
CA2858032A1 (en) * 2011-12-15 2013-06-20 Colgate-Palmolive Company Solubilized magnolol analogs
CA2857648A1 (en) * 2011-12-15 2013-06-20 Colgate-Palmolive Company Oral care or cleanser composition comprising solubilized magnolol analogs and ppg-1- peg-9 lauryl glycol ether
MX341440B (es) 2011-12-15 2016-08-18 Colgate Palmolive Co Analogos de magnolol solubilizados.
US9000231B2 (en) 2011-12-20 2015-04-07 Colgate-Palmolive Company Processes for making magnolol and derivatives thereof
WO2013095364A1 (en) 2011-12-20 2013-06-27 Colgate-Palmolive Company Processes for making magnolol analogs
EP2819638B1 (en) * 2012-03-02 2016-10-19 Colgate-Palmolive Company Oral care compositions
MX345485B (es) * 2012-12-07 2017-01-31 Lozoya Legorreta Xavier Composiciones equibióticas y métodos para el tratamiento de enfermedad periodontal y/o halitosis en animales.
WO2014115156A1 (en) 2013-01-23 2014-07-31 Colgate-Palmolive Company Processes for making magnolol derivatives
WO2014131191A1 (en) * 2013-03-01 2014-09-04 Johnson & Johnson Consumer Companies, Inc. A composition containing honokiol and/or magnolol and uses thereof
DE102013205603A1 (de) * 2013-03-28 2014-10-02 Beiersdorf Ag Farbstabile kosmetische Zubereitung
CN105997743A (zh) * 2016-07-17 2016-10-12 张学健 一种天然植物成份抗过敏牙膏
US10110246B1 (en) 2017-09-29 2018-10-23 Djuro G. Zrilic Δ-Σ methods for frequency deviation measurement of know nominal frequency value
CN117941682A (zh) 2017-12-22 2024-04-30 联合利华知识产权控股有限公司 抗微生物组合物
CN111096932B (zh) * 2018-10-29 2022-07-15 好维股份有限公司 一种口腔护理组合物
MX2021007084A (es) 2018-12-18 2021-08-11 Unilever Ip Holdings B V Una composicion antimicrobiana.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5785319A (en) * 1980-11-16 1982-05-28 Tsurui Yakuhin Kogyo Kk Agent for dental caries
JPH0676306B2 (ja) * 1984-11-22 1994-09-28 ライオン株式会社 口腔用組成物
JPH0733649A (ja) * 1993-07-19 1995-02-03 Kanebo Ltd 抗う蝕剤
US5614174A (en) 1994-11-14 1997-03-25 Colgate Palmolive Company Stabilized dentifrice compositions containing reactive ingredients
KR0176015B1 (ko) * 1996-03-26 1999-03-20 서치영 치주질환 예방 및 치료제 조성물
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6544409B2 (en) 2001-05-16 2003-04-08 Petroleo Brasileiro S.A. - Petrobras Process for the catalytic oxidation of sulfur, nitrogen and unsaturated compounds from hydrocarbon streams
CN1147286C (zh) 2001-07-18 2004-04-28 广州美晨股份有限公司 一种中药牙膏
RU2004138556A (ru) * 2002-06-25 2005-08-10 Вм. Ригли Дж. Компани (Us) Продукт с коричным альдегидом, освежающий дыхание и дезинфицирующий полость рта
US20060127329A1 (en) 2004-12-10 2006-06-15 Colgate-Palmolive Company Tartar control oral care composition containing extract of magnolia
US8900644B2 (en) 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US20060140885A1 (en) 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
CN101132806A (zh) * 2004-12-29 2008-02-27 高露洁-棕榄公司 使用木兰提取物减少口腔组织炎症的方法
CN101883573B (zh) 2007-10-01 2013-03-13 高露洁-棕榄公司 含有植物提取物的口腔组合物
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物
TWI422382B (zh) * 2010-02-24 2014-01-11 Colgate Palmolive Co 加強木蘭活性物之溶解度及傳送的組成物

Also Published As

Publication number Publication date
BR112012019190A2 (pt) 2018-03-27
CA2787965A1 (en) 2011-09-01
AU2011220790A1 (en) 2012-08-16
AU2011220790B2 (en) 2013-06-27
EP2539022B1 (en) 2018-08-01
EP2539022A2 (en) 2013-01-02
CA2787965C (en) 2015-11-24
ZA201205804B (en) 2015-03-25
RU2012140346A (ru) 2014-03-27
CN103025305A (zh) 2013-04-03
TWI459957B (zh) 2014-11-11
JP2013520518A (ja) 2013-06-06
TW201141498A (en) 2011-12-01
WO2011106493A3 (en) 2012-12-27
MY161595A (en) 2017-04-28
PH12012501522A1 (en) 2019-07-10
MX2012008717A (es) 2012-08-17
US8956592B2 (en) 2015-02-17
JP2015212274A (ja) 2015-11-26
WO2011106493A2 (en) 2011-09-01
US20120308489A1 (en) 2012-12-06
SG182711A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
AR080295A1 (es) Composiciones para el cuidado bucal y metodos de tratamiento
AR080294A1 (es) Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
UA102497C2 (ru) Антивирусная композиция для терапевтического применения in vivo, содержащая (-)-карвон, (+)-карвон, гераниол и дополнительный эфиромасличный компонент
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
CL2012001971A1 (es) Compuestos derivados de 1-piperazinil-3-piridin-carboxilato, como bloqueadores de los canales de sodio dependientes de voltaje; composicion farmaceutica; y su uso para el tratamiento de enfermedades respiratorias o del tracto respiratorio tal como asma, epoc, tos, silicosis, entre otras.
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
MX2015005148A (es) Formas il-15r alfa, celulas que expresan las formas de il-15 alfa, y usos terapeuticos de il-15r alfa y complejos il-15/il-15r.
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
CU20120171A7 (es) Triazolopiridinas sustituidas
ECSP12012031A (es) Composición farmacéutica que comprende oligopéptidos
CU20140068A7 (es) Triazolopiridinas sustituidas
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
EA201500375A1 (ru) Композиция для ухода за ротовой полостью
AR085042A1 (es) Composiciones de cuidado oral con extracto de magnolia
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
FR2968558B1 (fr) Composition a base d'extrait d'algues a usage bucco-dentaire
CL2015000848A1 (es) Uso de un compuesto de propilmetilfenol, o una composición que lo comprende, para producir una composición farmacéutica y/o nutracéutica para el tratamiento y/o profilaxis de la anemia infecciosa del salmón (isa) (divisional sol. n° 2654-12).
PH12014501265A1 (en) Solubilized magnolol analogs
BR112014013327A2 (pt) composições para cuidado oral
MX2015004312A (es) Formulacion de aroma y fragancia (i).
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.
CL2012001203A1 (es) Compuestos derivados de 4-aminociclohexano modulares del receptor arl1; proceso para la preparacion de los compuestos; medicamento que comprende uno de los compuestos; y uso de los componpuestos en la preparacion de medicamentos para el tratamiento del dolor, en especial el dolor neuropatico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure